Independent association of a 17q21 variant with exacerbations in type 2–low adult asthma
Background: The genetic factors contributing to exacerbations in type 2–low asthma are not well understood. Objective: We sought to clarify the association between variants in gasdermin B/orosomucoid-like 3 (GSDMB/ORMDL3) on 17q21 and exacerbations in type 2–low asthma. Methods: This follow-up study...
Saved in:
Similar Items
-
Elevated mepolizumab levels in patients with severe asthma responsive to 1 year’s mepolizumab treatment
by: Takayasu Nishimaki, MD, et al.
Published: (2025-05-01) -
Consensus from European experts on severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: Results from the OverSEA Delphi study
by: Claus Bachert, MD, PhD, et al.
Published: (2025-11-01) -
Levels of total IgE versus specific IgE during childhood for defining and predicting T2-high asthma
by: Tamo Sultan, MD, et al.
Published: (2024-12-01) -
Risk factors for asthma exacerbations
by: Lauri Nordman, MD, et al.
Published: (2025-08-01) -
Tezepelumab achieves improvement of severe uncontrolled asthma and rhinosinusitis: Case series
by: Shigesato Inoue, MD, et al.
Published: (2025-05-01)